Healthcare and Distribution Services - Audon Trap & Partners
Healthcare and Distribution Services - Audon Trap & Partners
Healthcare and Distribution Services - Audon Trap & Partners
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Generic Drugs<br />
Laboratorios Rider S.A. Synthon Holding B.V. Advisor to seller<br />
IB <strong>Partners</strong> acted as exclusive financial advisor to the shareholders of Laboratorios<br />
Rider S.A. (“Rider”) on the origination, execution, <strong>and</strong> structuring of the transaction.<br />
Holl<strong>and</strong> Corporate Finance was key in identifying Synthon, the purchaser. IB<br />
<strong>Partners</strong> ran a global private competitive auction process with participation of a full<br />
range of pharmaceutical companies.<br />
The shareholders of Rider <strong>and</strong> Synthon Holding BV (“Synthon”) reached an<br />
agreement in which Synthon acquired Rider, which continues to operate under the<br />
same name.<br />
Rider is a Chilean company specializing in the manufacture <strong>and</strong> distribution of<br />
pharmaceutical products, OTC drugs, <strong>and</strong> cosmetics, both under its own br<strong>and</strong>s as<br />
well as licensed br<strong>and</strong>s. Synthon is a Netherl<strong>and</strong>s-based company specializing in<br />
generic drugs, hybrids, <strong>and</strong> biotechnology products; it has developed more than<br />
500 patents in 20 countries which are licensed by pharmaceutical companies<br />
worldwide.<br />
Merck Pharmaceutical Ltd. Europharm Laboratories Advisor to buyer<br />
Co. Ltd.<br />
Europharm Laboratories Co. Ltd., a private company, is one of the leading<br />
pharmaceutical manufacturers in Hong Kong. Merck Pharmaceutical Ltd. is a global<br />
pharmaceuticals <strong>and</strong> chemicals group with a worldwide presence including the<br />
Peoples’ Republic of China.<br />
Quam Capital Ltd. was appointed by Europharm in its acquisition of the China<br />
generic drug manufacturing division of Merck. Quam identified <strong>and</strong> introduced the<br />
target company to Europharm. As a result of this acquisition Europharm has been<br />
able to significantly increase its China generic drug manufacturing capability.<br />
Pangeo Pharma, Inc. Marketing/Licensing Advisor to<br />
Management<br />
Pangeo Pharma, now part of Pharmascience, Inc., is a specialty Canadian<br />
Pharmaceutical company involved in Consumer Health products <strong>and</strong> Private Labels.<br />
Pangeo was looking to develop relationships with several Japanese Pharmaceutical<br />
companies to license <strong>and</strong> market products for treatment of certain Cardio-Vascular<br />
conditions.<br />
Morgen, Evan & Company assisted Pangeo in setting up these relationships with<br />
various Japanese Pharmaceutical companies.<br />
M&A International Inc.<br />
member firm:<br />
IB <strong>Partners</strong><br />
Quam Capital Limited<br />
Morgen, Evan & Company,<br />
Inc.<br />
21
Change language